Triple negative breast cancer is an aggressive subtype of breast cancer characterized by lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2) and accounts for more than 10% of all breast cancers10,11. This evidence concerns the gene ESR1 and breast cancer.